Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study

BACKGROUND: It is unclear whether nonvitamin K antagonist oral anticoagulants (NOACs) can mitigate dementia development in atrial fibrillation. We compared dementia development among users of NOACs or warfarin in patients with atrial fibrillation with no prior neurological diagnoses. METHODS AND RES...

Descripción completa

Detalles Bibliográficos
Autores principales: Søgaard, Mette, Skjøth, Flemming, Jensen, Martin, Kjældgaard, Jette Nordstrøm, Lip, Gregory Y. H., Larsen, Torben Bjerregaard, Nielsen, Peter Brønnum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585353/
https://www.ncbi.nlm.nih.gov/pubmed/31138001
http://dx.doi.org/10.1161/JAHA.118.011358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585353/
https://www.ncbi.nlm.nih.gov/pubmed/31138001
http://dx.doi.org/10.1161/JAHA.118.011358

Ejemplares similares